期刊文献+

SU11248对骨髓瘤细胞U266增殖及凋亡作用的实验研究 被引量:4

Effect of SU11248 on proliferation and apoptosis of myeloma cell line U266
下载PDF
导出
摘要 目的:探讨SU11248对骨髓瘤细胞U266的生物学效应的影响及其作用机制。方法:应用MTT法检测SU11248对U266细胞增殖能力的影响;用流式细胞技术检测细胞的DNA倍体及细胞周期变化、用凝胶电泳分析DNA片段化、用脱氧核糖核苷酸末端转移酶介导的缺口末端标记法(TUNEL)检测SU11248对U266细胞凋亡的影响;以RT-PCR法检测3.0μg/mlSU11248作用U266细胞后c-myc、hTERT、Bcl-2、BaxmRNA表达变化。结果:SU11248可明显抑制U266细胞增殖(P<0.05),呈现剂量和时间依赖性,半数抑制浓度(IC50)约为3.0μg/ml。SU11248可将U266细胞阻滞于G0/G1期,并呈现剂量依赖性;能诱导U266细胞呈现典型的DNA梯状带;促进细胞原位凋亡。3.0μg/mlSU11248作用后,U266细胞c-myc、hTERT、Bcl-2mRNA表达水平呈时间依赖性降低,而BaxmRNA表达水平呈时间依赖性增强。结论:SU11248能抑制U266细胞增殖,诱导其凋亡,其作用机制可能与下调U266细胞Bcl-2、c-myc和hTERT的表达及上调Bax的表达有关。 Objective:To investigate the effect of SUl1248 proliferation and apoptosis of multiple myeloma cell line U266 in vitro and analyze its mechanisms. Methods:Effect of SUl1248 on proliferation of U266 ceils was detected by MTT assay.The ability of SUl1248 to induce apoptosis of U266 cells was examined by cell cycle analysis,TUNEL and DNA fragmentation. Expression of c-myc, hTERT, Bcl-2 and Bax mRNA in U266 cells was assessed by RT-PCR analysis.Results:The proliferation of U266 cells was inhibited by SUl1248 in dose- and time- dependent manners (P 〈 0.05). The concentration of 50% growth inhibition (ICS0) of SU11248 for U266 was 3.0 μg/ml. SUl1248 induced G0/G1 phase of U266 cells, and induced U266 cell apoptosis as measured by detection of DNA fragmentation, flow cytometry and TUNEL. These data showed that SUl1248 induced apoptosis for U266 cells in dose- and time- dependent manners. After treating U266 cells with 3.0 μg/ml SU11248 at different time points, expressing level of c-myc, hTERT and Bcl-2 mRNA was reduced significantly and expressing level of Bax mRNA was increased significandy in a time-dependent manner( P 〈 0.05). Conclusion: SU11248 can inhibit the growth of U266 cells and induce the apoptosis of U266 cells. Its mechanism may be closely related with reduction the expression of c-myc, hTERT, Bcl-2 mRNA and enhancement the expression of Bax mRNA.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2009年第4期312-316,共5页 Chinese Journal of Immunology
基金 福建省教育厅(JA07085) 福建省医科大学教授基金资助项目
关键词 SU11248 多发性骨髓瘤 U266细胞 凋亡 SU11248 Multiple myeloma U266 cell Apoptosis
  • 相关文献

参考文献8

  • 1Rock E P, Goodman V, Jiang J X et al. Food and drug adminstration drug approval summary: sunitinib malate for the treatment of gastrointestinal stromal tumor and advanced renal cell carcinoma[J]. Oncologist,2007; 12 (1):107-113.
  • 2Goodman V L, Rock E P, Dagher R et al. Approval summary sunitinib for the treatment of imatinib refractory or intolerant gastrointestinal stromal tumors and advancedrenal cell carcinoma [ J ]. Clin Cancer Res, 2007 ; 13 (5) : 1367-1373.
  • 3Motzer R J, Michaelson M D, Redman B Get al. Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma [J]. J CIin Oncol,2006;24( 1): 16-24.
  • 4Faivre S, Delbaldo C, Vera K et al. Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral muhitarget tyrosine kinase inhibitor, in patients with cancer [ J ]. J Clin Oncol, 2006 ; 24 ( I ) : 25-35.
  • 5Fiedler W, Serve H, Dohner H et al. A phase Ⅰ study of SU11248 in tile treatment of patients with refractory or resistant acute myeloid leukemia (AML) or not amenable to conventional therapy for the disease [J]. Blood,2005 ; 105(3) :986-993.
  • 6Chow L Q. Eckhardt S G. Sunitinib: from rational design to clinical efficacy[J] .J Clin Oncol,2007;25(7):884-896.
  • 7Ohvai Z N, Milliman C L, Korsmeyer Set al. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death [J]. Cell, 1993;74(4) :609-619.
  • 8Jiang F, Bao j, Li P et al. Induction of ovarian cancer cell apoptosis by 1, 25-Dihydroxyvitamin D3 through the down-regulation of telomerase[ J]. J Biol Chem, 2004 ; 279 ( 51 ) : 53213-53221.

同被引文献41

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部